Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1996
10/22/1996US5567713 Hypoglycemic agents
10/22/1996US5567689 Methods for increasing uridine levels with L-nucleosides
10/21/1996CA2174602A1 .alpha.-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
10/17/1996WO1996032489A1 Glucose-inducible recombinant viral vector
10/17/1996WO1996032414A1 Glucagon-like peptide-2 and its therapeutic use
10/17/1996WO1996032379A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
10/17/1996WO1996032087A2 Transgenic fish in the treatment of diabetes
10/17/1996WO1996032003A2 Tetrahydroimidazopyridoindolediones and their use as medicaments
10/17/1996WO1996027006A3 Human vegf-specific antisense oligonucleotides
10/17/1996WO1996026728A3 Use of moxonidine for the treatment of atherosclerosis
10/17/1996CA2226759A1 Tetracycline compounds used as cgmp specific pde inhibitors
10/17/1996CA2218225A1 Glucagon-like peptide-2 and its therapeutic use
10/17/1996CA2217707A1 Indole derivatives as cgmp-pde inhibitors
10/17/1996CA2215987A1 Glucose-inducible recombinant viral vector
10/17/1996CA2191969A1 Transgenic fish in the treatment of diabetes
10/16/1996EP0737670A1 Tricyclic amides, processes for their preparation, and pharmaceutical compositions containing them
10/16/1996EP0737206A1 Glucagon analogs with serine replacements at position 16 having antagonistic activity
10/16/1996EP0737200A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
10/16/1996EP0737199A1 Method for preparing concentrated biologically active silicon compounds
10/16/1996EP0737193A1 Pyrazolopyridine adenosine antagonists
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996EP0737070A1 Vitamin d 3? analogues and pathway to mediate disorders
10/16/1996EP0601052B1 Therapeutic method for the treatment of iddm
10/16/1996EP0543945B1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
10/16/1996EP0482175B1 Fault tolerant computer system
10/16/1996CN1133598A Acylated insulin
10/16/1996CN1133296A 11 beta-aromatic group-4-estraene and acid additive salt application in medicine
10/16/1996CN1133287A Inhibitor for squalene synthetic enzyme
10/15/1996US5565586 Oxidative process for the preparation of allyl quinone derivatives
10/15/1996US5565442 Dissolving in solvent with antioxidant and polyoxyalkyl stabilizer; compositing with carrier or excipient to impart solid characteristics; desolventizing; useful in conditions of vitamin d deficiency
10/15/1996US5565440 Antiinflammatory, antipyritic, analgesic, antirheumatic, antiarthritic or antiosteoprosis agent
10/15/1996US5565351 Reducing the muscle protein loss by reducing proteolysis
10/15/1996CA2029703C Oxazolidinedione hypoglycemic agents
10/15/1996CA1338647C Inhibitors of lysyl oxidase
10/15/1996CA1338646C (arylsulphonyl) nitromethanes, processes for their preparation and their use in pharmaceutical compositions
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031530A1 Novel peptides and remedy for bone diseases containing the same as active ingredient
10/10/1996WO1996031511A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/10/1996WO1996031499A1 Novel heterocyclic compounds
10/10/1996WO1996031498A1 Novel heterocyclic compounds
10/10/1996WO1996031497A1 Novel heterocyclic compounds
10/10/1996WO1996031474A1 Novel heterocyclic compounds
10/10/1996WO1996031471A1 Novel method
10/10/1996WO1996031468A1 Novel heterocyclic compounds
10/10/1996WO1996031242A1 RECOMBINANT β-CELL AND USES THEREOF
10/10/1996WO1996031223A1 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel
10/10/1996WO1996031129A1 Therapeutic food composition and method to diminish blood sugar fluctuations
10/10/1996WO1996031128A1 Cereal food product high in soluble fiber
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996WO1996001430A3 Screening for nuc inhibitors
10/10/1996CA2217701A1 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel
10/10/1996CA2217652A1 Recombinant .beta.-cell and uses thereof
10/10/1996CA2217206A1 Novel heterocyclic compounds
10/10/1996CA2217202A1 Novel heterocyclic compounds
10/10/1996CA2217200A1 Novel method
10/10/1996CA2217197A1 Novel heterocyclic compounds
10/10/1996CA2217194A1 Novel heterocyclic compounds
10/10/1996CA2217130A1 Novel heterocyclic compounds
10/10/1996CA2215469A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
10/09/1996EP0736526A1 Pyrazolidine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
10/09/1996EP0736256A1 Enantiomerically-enhanced nutritional energy substrates
10/09/1996EP0736039A1 Compounds with growth hormone releasing properties
10/09/1996EP0736038A1 Compounds with growth hormone releasing properties
10/09/1996EP0736028A1 Indoline derivatives, method of preparation and their use as pharmaceuticals
10/09/1996EP0736006A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
10/09/1996EP0735896A1 Parathyroid hormone formulation
10/09/1996EP0735888A1 Purine compositions and methods for administration
10/09/1996EP0594578B1 Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
10/09/1996CN1133047A Therapeutic peptide derivatives
10/09/1996CN1133040A Benzothiophenes and related compounds as estrogen agonists
10/09/1996CN1132745A Substituted henzoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
10/09/1996CN1132626A Improved calcium dietary supplement
10/09/1996CN1132607A Fortified fruit juices
10/08/1996US5563054 Culturing streptomyces in nutrient medium
10/08/1996CA2073876C Ruminal bacterium for preventing acute lactic acidosis
10/08/1996CA2010768C Acidic polycyclic ether antibiotic
10/07/1996CA2173270A1 Enantiomerically-enhanced nutritional energy substrates
10/04/1996CA2173305A1 Pyrazolidine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
10/03/1996WO1996030762A1 Insulin mimetic and enhancer assay
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030343A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030332A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/03/1996WO1996030328A1 Terminal carboxy or tetrazole groups containing dialkyl ethers
10/03/1996WO1996030048A1 Protein kinase c inhibitors
10/03/1996WO1996030042A2 Methods of treating inflammation and compositions therefor
10/03/1996WO1996030031A1 Isolated stromal cells and methods of using the same
10/03/1996WO1996030007A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
10/03/1996CA2216806A1 Insulin mimetic and enhancer assay
10/03/1996CA2216707A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2215143A1 Isolated stromal cells and methods of using the same
10/03/1996CA2214988A1 Method of treating inflammation and compositions therefor
10/02/1996EP0735141A2 Process for preparation of benzo(b)thiophene glucuronides
10/02/1996EP0735038A1 Protein kinase C inhibitors
10/02/1996EP0734721A2 Method of incorporating drugs into a polymer component of stents
10/02/1996EP0734396A1 ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY
10/02/1996EP0734376A1 Vitamin d amine and amide derivatives
10/02/1996EP0734373A1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
10/02/1996EP0734371A1 Novel retinoid conjugate compounds and methods for treating skin aging
10/01/1996US5561160 Administering glucaric acid or salt thereof
10/01/1996US5561150 Tricyclic pyrazole derivatives